Concepedia

Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban

Eleanor Jing Yi Cheong, Denise Wun Xi Teo, Denise Xin Yi Chua, Eric Chun Yong Chan

Drug Metabolism and Disposition · 2019 · 32 citations · 46 references

DOIFull text

Open access

References

46

Worldwide Epidemiology of Atrial Fibrillation

Sumeet S. Chugh, Rasmus Havmoeller, Kumar Narayanan et al. · Circulation · 2013 · 4.4K citations · Full text

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Craig T. January, L. Samüel Wann, Joseph S. Alpert et al. · Journal of the American College of Cardiology · 2014 · 3K citations

, , +10

Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

Trudy Rodgers, Malcolm Rowland · Journal of Pharmaceutical Sciences · 2006 · 919 citations

, , +12

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

Dagmar Kubitza, Michael Becka, Barbara Voith et al. · Clinical Pharmacology & Therapeutics · 2005 · 652 citations

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

Dagmar Kubitza, Michael Becka, Georg Wensing et al. · European Journal of Clinical Pharmacology · 2005 · 648 citations

, , +5